By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...

Pfizer BioNTech halt COVID vaccine study in adults 50-64 due to slow enrollment, citing inability to generate relevant postmarketing data.

BRUSSELS, April 1 (Reuters) - A Belgian court on Wednesday ordered Poland and Romania to take delivery of 1.9 billion euros ($2.2 billion) worth of COVID-19 vaccines made by Pfizer and BioNTech in a ...

Pfizer has emerged victorious in a legal brawl with Poland and Romania over contested COVID vaccine orders, with a Belgian ...

Poland and Romania have been ordered by a Belgian court to pay Pfizer Inc. €1.9 billion ($2.2 billion) for Covid-19 vaccines ...

The trial is tied to a post-marketing commitment that FDA Commissioner Martin Makary put in place last year for all approved ...

In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug ...

There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot because of a lack of ...

Pfizer and Valneva have blamed “fewer than anticipated” Lyme disease cases for the failure of their phase 3 trial to hit its ...

Pfizer (PFE) stock is in focus as the company plans to close its South San Francisco research site and office by April. Read ...

Pfizer Inc.’s vaccine to protect against a potentially dangerous respiratory infection will be offered to about three million ...

BRUSSELS, April 1 (Reuters) - A Belgian court on Wednesday ordered Poland and Romania to take delivery of 1.9 billion euros ...